(Q35400935)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14062088%20AND%20SRC:MED&resulttype=core&format=json

26 November 2019

review article

1 reference

title

THE ETIOLOGY AND THERAPY OF ATYPICAL PNEUMONIA (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14062088%20AND%20SRC:MED&resulttype=core&format=json

26 November 2019

1

W A CLYDE

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14062088%20AND%20SRC:MED&resulttype=core&format=json

26 November 2019

2

F W DENNY

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14062088%20AND%20SRC:MED&resulttype=core&format=json

26 November 2019

publication date

1 September 1963

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14062088%20AND%20SRC:MED&resulttype=core&format=json

Medical Clinics of North America

26 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14062088%20AND%20SRC:MED&resulttype=core&format=json

26 November 2019

volume

47

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14062088%20AND%20SRC:MED&resulttype=core&format=json

26 November 2019

page(s)

1201-1218

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14062088%20AND%20SRC:MED&resulttype=core&format=json

Interstitial plasma cell pneumonia

26 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2933528-3

7 January 2021

Eaton agent pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2933528-3

Respiratory disease in volunteers infected with Eaton agent: a preliminary report

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2933528-3

Growth on artificial medium of an agent associated with atypical pneumonia and its identification as a PPLO.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2933528-3

Recovery of PPLO of atypical pneumonia on artificial agar medium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2933528-3

Growth of Eaton PPLO in broth and preparation of complement fixing antigen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2933528-3

Fluorescent-stainable antibodies to the Eaton agent in human primary atypical pneumonia transmission studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2933528-3

Demonstration of Eaton's agent in tissue culture

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2933528-3

Hemolysis in Identifying Eaton's Pleuropneumonia-Like Organism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2933528-3

Studies on Growth of Eaton's Agent in Tissue Culture

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2933528-3

Role of Eaton agent in disease of lower respiratory tract: evidence for infection in adults.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2933528-3

Cytological studies of chick embryo cells infected with the virus of primary atypical pneumonia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2933528-3

STUDIES ON THE ETIOLOGY OF PRIMARY ATYPICAL PNEUMONIA : A FILTERABLE AGENT TRANSMISSIBLE TO COTTON RATS, HAMSTERS, AND CHICK EMBRYOS.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2933528-3

STUDIES ON THE ETIOLOGY OF PRIMARY ATYPICAL PNEUMONIA : II. PROPERTIES OF THE VIRUS ISOLATED AND PROPAGATED IN CHICK EMBRYOS.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2933528-3

STUDIES ON THE ETIOLOGY OF PRIMARY ATYPICAL PNEUMONIA : III. SPECIFIC NEUTRALIZATION OF THE VIRUS BY HUMAN SERUM

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2933528-3

Action of aureomycin and chloromycetin on the virus of primary atypical pneumonia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2933528-3

Bronchitis, pneumonitis and pneumonia in University of Wisconsin students

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2933528-3

Effect of aureomycin on the development of cold agglutinins in primary atypical pneumonia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2933528-3

CLINICAL EXPERIENCE WITH AUREOMYCIN

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2933528-3

Acute respiratory illnesses among children and adults. Field study of contemporary importance of several viruses and appraisal of the literature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2933528-3

7 January 2021

Eaton agent pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2933528-3

Studies on primary atypical pneumonia. I. Localization, isolation, and cultivation of a virus in chick embryos

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2933528-3

Studies on primary atypical pneumonia. II. Observations concerning the development and immunological characteristics of antibody in patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2933528-3

Effect of an organic gold salt on Eaton's primary atypical pneumonia agent and other observations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2933528-3

Aureomycin in primary atypical pneumonia; a controlled evaluation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2933528-3

Chemotherapy of primary atypical pneumonia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2933528-3

Eaton Agent Pneumonia— Clinical Features

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2933528-3

COLD AGGLUTININS (AUTOHEMAGGLUTININS) IN PRIMARY ATYPICAL PNEUMONIAS

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2933528-3

An evaluation of aureomycin therapy in primary atypical pneumonia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2933528-3

SEROLOGICAL REACTIONS WITH AN INDIFFERENT STREPTOCOCCUS IN PRIMARY ATYPICAL PNEUMONIA

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2933528-3

Primary atypical nonbacterial pneumonia; an evaluation of the efficacy of antibiotic therapy in one hundred eighteen cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2933528-3

Studies on sensitivity to streptomycin of the atypical pneumonia agent.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2933528-3

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0025-7125(16)33528-3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14062088%20AND%20SRC:MED&resulttype=core&format=json

26 November 2019

1 reference